Document Detail


Effect of high soy diet on the cerebrovasculature and endothelial nitric oxide synthase in the ovariectomized rat.
MedLine Citation:
PMID:  20197113     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
High soy (HS) diets are neuroprotective and promote vascular dilatation in the periphery. We hypothesized that an HS diet would promote vascular dilatation in the cerebrovasculature by mimicking estradiol's actions on the endothelial nitric oxide synthase (eNOS) system including increasing eNOS expression and decreasing caveolin-1 expression to increase nitric oxide (NO) production. Ovariectomized rats were fed HS or a soy-free diet (SF)+/-low physiological estradiol (E2) for 4weeks. Neither E2 nor HS altered middle cerebral artery (MCA) structure or vascular responses to acetylcholine, serotonin, or phenylephrine. Estradiol enhanced bradykinin-induced relaxation in an eNOS-dependent manner. Although E2 and HS increased eNOS mRNA expression in the brain and cerebrovasculature, they had no effect on eNOS protein expression or phosphorylation in the MCA. However, E2 decreased caveolin-1 protein in the MCA. In MCAs neither E2 nor HS altered estrogen receptor (ER) alpha expression, but E2 did reduce ER beta levels. These data suggest that HS diets have no effect on vascular NO production, and that E2 may modulate basal NO production by reducing the expression of caveolin-1, an allosteric inhibitor of NOS activity. However, the effects of E2 and HS on the cerebrovasculature are small and may not underlie their protective actions in pathological states.
Authors:
Derek A Schreihofer; Christian Deutsch; Tara Lovekamp-Swan; Jennifer C Sullivan; Anne M Dorrance
Related Documents :
10919933 - Isoflavone phytoestrogens consumed in soy decrease f(2)-isoprostane concentrations and ...
15617573 - Dietary isoflavones alter regulatory behaviors, metabolic hormones and neuroendocrine f...
16298873 - Effects of miglyol 812 on rats after 4 weeks of gavage as compared with methylcellulose...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2010-03-01
Journal Detail:
Title:  Vascular pharmacology     Volume:  52     ISSN:  1879-3649     ISO Abbreviation:  Vascul. Pharmacol.     Publication Date:    2010 May-Jun
Date Detail:
Created Date:  2010-04-23     Completed Date:  2010-08-02     Revised Date:  2011-07-28    
Medline Journal Info:
Nlm Unique ID:  101130615     Medline TA:  Vascul Pharmacol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  236-42     Citation Subset:  IM    
Affiliation:
Department of Physiology, Medical College of Georgia, Augusta, GA 30912-3000, USA. dschreihofer@mcg.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Caveolin 1 / drug effects,  genetics
Diet
Estradiol / pharmacology
Estrogen Receptor beta / drug effects,  metabolism
Female
Gene Expression Regulation, Enzymologic / drug effects
Isoflavones / administration & dosage,  pharmacology*
Middle Cerebral Artery / drug effects,  metabolism
Nitric Oxide / metabolism
Nitric Oxide Synthase Type III / drug effects*,  genetics,  metabolism
Ovariectomy
RNA, Messenger / metabolism
Rats
Rats, Sprague-Dawley
Soybeans / chemistry*
Vasodilation / drug effects*
Grant Support
ID/Acronym/Agency:
NIH RO1 HL0077385/HL/NHLBI NIH HHS; R01 AT001882-04/AT/NCCAM NIH HHS; R01 HL077385-01/HL/NHLBI NIH HHS; R01AT001882/AT/NCCAM NIH HHS
Chemical
Reg. No./Substance:
0/Caveolin 1; 0/Estrogen Receptor beta; 0/Isoflavones; 0/RNA, Messenger; 10102-43-9/Nitric Oxide; 50-28-2/Estradiol; EC 1.14.13.39/Nitric Oxide Synthase Type III
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  E-screen and vitellogenin assay for the detection of the estrogenic activity of alkylphenols and tra...
Next Document:  Congenital long QT syndrome and 2:1 atrioventricular block: an optimistic outcome in the current era...